Recent Advances in the Histopathology, Molecular Biology, and Treatment of Kaposi Sarcoma: A Contemporary Review
International Journal of Molecular Sciences · 16.10.2025 · 26 (20) · 10058
DOI: 10.3390/ijms262010058 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.10.2025. Verfasst von Tayarv Jayd Bagratee und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Laboratory Medicine and Medical Sciences, College of Health Science, University of KwaZulu-Natal, Durban 4041, South Africa. Hauptthemen laut MEDLINE: Sarcoma, Kaposi, Herpesvirus 8, Human. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kaposi sarcoma (KS) is an intermediate-grade vascular tumour that has undergone major treatment and diagnostic breakthroughs following the discovery of Human herpesvirus 8 (HHV8). Whilst classically described in Eastern European populations, the endemic and epidemic forms of KS have facilitated its association with AIDS. This was led by the detection of HHV8 by PCR, and thereafter, immunohistochemically. This not only enabled the recognition and diagnosis of complex histopathological KS subtypes but also facilitated distinction from its mimickers, including acroangiodermatitis and pyogenic granuloma. Recent advances in the viral genomics of HHV8 have expanded the diagnostic landscape of KS clinically and molecularly. The latent phase of replication in the HHV8 lifecycle reveals numerous angiogenic and inflammatory factors. Novel therapies targeting these viral–human molecular interactions may prove useful. However, this is highly dependent on the clonal nature of KS. Conflicting research outcomes demonstrate varying viewpoints on the clonal (monoclonal/oligoclonal/polyclonal) nature of KS, heightening the tumoural versus inflammatory pseudoneoplastic controversy. Understanding the clinical context of KS is fundamental to understanding its clonality, and a dearth of this clinical information in recent studies appears to be the critical factor in determining the true clonal nature of KS. The current molecular landscape, histopathology, treatment options, and opinions on clonality are critically reviewed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Laboratory Medicine and Medical Sciences, College of Health Science, University of KwaZulu-Natal, Durban 4041, South Africa.
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban 4013, South Africa.
- International Foundation for Integrative Medical Research, Cape Town 8001, South Africa.
- Department of Anatomical Pathology, National Health Laboratory Service and School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4091, South Africa.
- Department of Anatomical Pathology, Nexomic Laboratories, Durban 4001, South Africa.
- Department of Anatomical Pathology, Walter Sisulu University, Mthatha 5099, South Africa.
ORCID-Profile: Veron Ramsuran
Zitieren
APA
Bagratee, T. J., Ramsuran, V., Msimang, M., & Ramdial, P. K. (2025). Recent Advances in the Histopathology, Molecular Biology, and Treatment of Kaposi Sarcoma: A Contemporary Review. International Journal of Molecular Sciences, 26(20), 10058. https://doi.org/10.3390/ijms262010058
Vancouver
Bagratee TJ, Ramsuran V, Msimang M, Ramdial PK. Recent Advances in the Histopathology, Molecular Biology, and Treatment of Kaposi Sarcoma: A Contemporary Review. International Journal of Molecular Sciences. 2025;26(20):10058. doi:10.3390/ijms262010058
BibTeX
@article{Bagratee2025,
author = {Bagratee, Tayarv Jayd and Ramsuran, Veron and Msimang, Mpumelelo and Ramdial, Pratistadevi Kanaye},
title = {Recent Advances in the Histopathology, Molecular Biology, and Treatment of Kaposi Sarcoma: A Contemporary Review},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {20},
pages = {10058},
doi = {10.3390/ijms262010058}
}
EUVIMED